Viewing Study NCT03161756


Ignite Creation Date: 2025-12-24 @ 11:19 PM
Ignite Modification Date: 2026-01-03 @ 8:48 AM
Study NCT ID: NCT03161756
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2017-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
Sponsor: Melanoma and Skin Cancer Trials Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module